Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of clinical oncology

Results: 1-25/472

Authors: FOLEY KM
Citation: Km. Foley, PAIN RELIEF INTO PRACTICE - RHETORIC WITHOUT REFORM, Journal of clinical oncology, 13(9), 1995, pp. 2149-2151

Authors: GULATI SC BITRAN JD
Citation: Sc. Gulati et Jd. Bitran, COST-EFFECTIVENESS ANALYSIS - SLEEPING WITH AN ENEMY OR A FRIEND, Journal of clinical oncology, 13(9), 1995, pp. 2152-2154

Authors: CLARK JW CHABNER BA
Citation: Jw. Clark et Ba. Chabner, SURAMIN AND PROSTATE-CANCER - WHERE DO WE GO FROM HERE, Journal of clinical oncology, 13(9), 1995, pp. 2155-2157

Authors: FERRELL BR DEAN GE GRANT M COLUZZI P
Citation: Br. Ferrell et al., AN INSTITUTIONAL COMMITMENT TO PAIN MANAGEMENT, Journal of clinical oncology, 13(9), 1995, pp. 2158-2165

Authors: SMITH TJ HILLNER BE NEIGHBORS DM MCSORLEY PA LECHEVALIER T
Citation: Tj. Smith et al., ECONOMIC-EVALUATION OF A RANDOMIZED CLINICAL-TRIAL COMPARING VINORELBINE, VINORELBINE PLUS CISPLATIN, AND VINDESINE PLUS CISPLATIN FOR NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2166-2173

Authors: EISENBERGER MA SINIBALDI VJ REYNO LM SRIDHARA R JODRELL DI ZUHOWSKI EG TKACZUK KH LOWITT MH HEMADY RK JACOBS SC VANECHO D EGORIN MJ
Citation: Ma. Eisenberger et al., PHASE-I AND CLINICAL-EVALUATION OF A PHARMACOLOGICALLY GUIDED REGIMENOF SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2174-2186

Authors: REYNO LM EGORIN MJ EISENBERGER MA SINIBALDI VJ ZUHOWSKI EG SRIDHARA R
Citation: Lm. Reyno et al., DEVELOPMENT AND VALIDATION OF A PHARMACOKINETICALLY BASED FIXED DOSING SCHEME FOR SURAMIN, Journal of clinical oncology, 13(9), 1995, pp. 2187-2195

Authors: KOBAYASHI K VOKES EE VOGELZANG NJ JANISCH L SOLIVEN B RATAIN MJ
Citation: K. Kobayashi et al., PHASE-I STUDY OF SURAMIN GIVEN BY INTERMITTENT INFUSION WITHOUT ADAPTIVE-CONTROL IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2196-2207

Authors: KELLY WK CURLEY T LEIBERTZ C DNISTRIAN A SCHWARTZ M SCHER HI
Citation: Wk. Kelly et al., PROSPECTIVE EVALUATION OF HYDROCORTISONE AND SURAMIN IN PATIENTS WITHANDROGEN-INDEPENDENT PROSTATE-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2208-2213

Authors: KELLY WK SCHER HI MAZUMDAR M PFISTER D CURLEY T LEIBERTZ C COHEN L VLAMIS V DNISTRIAN A SCHWARTZ M
Citation: Wk. Kelly et al., SURAMIN AND HYDROCORTISONE - DETERMINING DRUG EFFICACY IN ANDROGEN-INDEPENDENT PROSTATE-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2214-2222

Authors: BITTON RJ FIGG WD VENZON DJ DALAKAS MC BOWDEN C HEADLEE D REED E MYERS CE COOPER MR
Citation: Rj. Bitton et al., PHARMACOLOGICAL VARIABLES ASSOCIATED WITH THE DEVELOPMENT OF NEUROLOGIC TOXICITY IN PATIENTS TREATED WITH SURAMIN, Journal of clinical oncology, 13(9), 1995, pp. 2223-2229

Authors: LILENBAUM RC RATAIN MJ MILLER AA HARGIS JB HOLLIS DR ROSNER GL OBRIEN SM BREWSTER L GREEN MR SCHILSKY RL
Citation: Rc. Lilenbaum et al., PHASE-I STUDY OF PACLITAXEL AND TOPOTECAN IN PATIENTS WITH ADVANCED TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 13(9), 1995, pp. 2230-2237

Authors: MORGAN RJ MARGOLIN K RASCHKO J AKMAN S LEONG L SOMLO G SCANLON K AHN C CARROLL M DOROSHOW JH
Citation: Rj. Morgan et al., PHASE-I TRIAL OF CARBOPLATIN AND INFUSIONAL CYCLOSPORINE IN ADVANCED MALIGNANCY, Journal of clinical oncology, 13(9), 1995, pp. 2238-2246

Authors: HEIDEMAN RL KOVNAR EH KELLIE SJ DOUGLASS EC GAJJAR AJ WALTER AW LANGSTON JA JENKINS JJ LI YL GREENWALD C SANFORD RA KUN LE
Citation: Rl. Heideman et al., PREIRRADIATION CHEMOTHERAPY WITH CARBOPLATIN AND ETOPOSIDE IN NEWLY-DIAGNOSED EMBRYONAL PEDIATRIC CNS TUMORS, Journal of clinical oncology, 13(9), 1995, pp. 2247-2254

Authors: WARDE P GOSPODAROWICZ MK PANZARELLA T CATTON CN STURGEON JFG MOORE M GOODMAN P JEWETT MAS
Citation: P. Warde et al., STAGE-I TESTICULAR SEMINOMA - RESULTS OF ADJUVANT IRRADIATION AND SURVEILLANCE, Journal of clinical oncology, 13(9), 1995, pp. 2255-2262

Authors: ARMSTRONG C RUFFER J CORN B DEVRIES K MOLLMAN J
Citation: C. Armstrong et al., BIPHASIC PATTERNS OF MEMORY DEFICITS FOLLOWING MODERATE-DOSE PARTIAL-BRAIN IRRADIATION - NEUROPSYCHOLOGIC OUTCOME AND PROPOSED MECHANISMS, Journal of clinical oncology, 13(9), 1995, pp. 2263-2271

Authors: LOGOTHETIS CJ FINN LD SMITH T KILBOURN RG ELLERHORST JA ZUKIWSKI AA SELLA A TU SM AMATO RJ
Citation: Cj. Logothetis et al., ESCALATED MVAC WITH OR WITHOUT RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR THE INITIAL TREATMENT OF ADVANCED MALIGNANT UROTHELIAL TUMORS - RESULTS OF A RANDOMIZED TRIAL, Journal of clinical oncology, 13(9), 1995, pp. 2272-2277

Authors: STEPHENSON WT POIRIER SM RUBIN L EINHORN LH
Citation: Wt. Stephenson et al., EVALUATION OF REPRODUCTIVE CAPACITY IN GERM-CELL TUMOR PATIENTS FOLLOWING TREATMENT WITH CISPLATIN, ETOPOSIDE, AND BLEOMYCIN, Journal of clinical oncology, 13(9), 1995, pp. 2278-2280

Authors: VALONE FH KAUFMAN PA GUYRE PM LEWIS LD MEMOLI V DEO Y GRAZIANO R FISHER JL MEYER L MROZEKORLOWSKI M WARDWELL K GUYRE V MORLEY TL ARVIZU C FANGER MW
Citation: Fh. Valone et al., PHASE IA IB TRIAL OF BISPECIFIC ANTIBODY MDX-210 IN PATIENTS WITH ADVANCED BREAST OR OVARIAN-CANCER THAT OVEREXPRESSES THE PROTOONCOGENE HER-2/NEU/, Journal of clinical oncology, 13(9), 1995, pp. 2281-2292

Authors: MILLIKAN R HULKA B THOR A ZHANG YC EDGERTON S ZHANG XX PEI H HE M WOLD L MELTON LJ BALLARD D CONWAY K LIU ET
Citation: R. Millikan et al., P53 MUTATIONS IN BENIGN BREAST-TISSUE, Journal of clinical oncology, 13(9), 1995, pp. 2293-2300

Authors: WILLSON JKV HAAGA JR TREY JE STELLATO TA GORDON NH GERSON SL
Citation: Jkv. Willson et al., MODULATION OF O-6-ALKYLGUANINE ALKYLTRANSFERASE DIRECTED DNA-REPAIR IN METASTATIC COLON CANCERS, Journal of clinical oncology, 13(9), 1995, pp. 2301-2308

Authors: BUNT AMG HOGENDOORN PCW VANDEVELDE CJH BRUIJN JA HERMANS J
Citation: Amg. Bunt et al., LYMPH-NODE STAGING STANDARDS IN GASTRIC-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2309-2316

Authors: HILL M NORMAN A CUNNINGHAM D FINDLAY M WATSON M NICOLSON V WEBB A MIDDLETON G AHMED F HICKISH T NICOLSON M OBRIEN M IVESON T IVESON A EVANS C
Citation: M. Hill et al., IMPACT OF PROTRACTED VENOUS INFUSION FLUOROURACIL WITH OR WITHOUT INTERFERON ALFA-2B ON TUMOR RESPONSE, SURVIVAL, AND QUALITY-OF-LIFE IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2317-2323

Authors: WIESENFELD M OCONNELL MJ WIEAND HS GONCHOROFF NJ DONOHUE JH FITZGIBBONS RJ KROOK JE MAILLIARD JA GERSTNER JB PAZDUR R
Citation: M. Wiesenfeld et al., CONTROLLED CLINICAL-TRIAL OF INTERFERON-GAMMA AS POSTOPERATIVE SURGICAL ADJUVANT THERAPY FOR COLON-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2324-2329

Authors: SUNDARESAN N SACHDEV VP HOLLAND JF MOORE F SUNG M PACIUCCI PA WU LT KELLIGHER K HOUGH L
Citation: N. Sundaresan et al., SURGICAL-TREATMENT OF SPINAL-CORD COMPRESSION FROM EPIDURAL METASTASIS, Journal of clinical oncology, 13(9), 1995, pp. 2330-2335
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>